Neogen Corporation

    NEOG ·NASDAQ ·In Vitro & In Vivo Diagnostic Substances ·Inc. in MI
    Loading chart...

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent insider activity

    Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 1 transaction across 1 insider. Net: +370 shares, $4,370.

    Date Insider Role Action Shares Price Value
    2026-08-04 Nassif Mikheal indirect CEO Buy +370 $11.81 $4,370

    Source: SEC Form 4 filings.

    Next expected filings

    • ~2027-01-08 10-Q expected by 2027-01-08 (in 93 days)
    • ~2027-04-09 10-Q expected by 2027-04-09 (in 184 days)
    • ~2027-07-30 10-K expected by 2027-07-30 (in 296 days)
    • ~2027-10-07 10-Q expected by 2027-10-07 (in 365 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-10-07 10-Q Quarterly Report
    • 2026-10-06 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-08-21 DEF 14A Proxy Statement
    • 2026-08-07 8-K Officer/Director Change
    • 2026-07-30 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-07-30 10-K Annual Report
    • 2026-04-09 10-Q Quarterly Report
    • 2026-04-09 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-03-30 8-K Officer/Director Change
    • 2026-01-08 10-Q Quarterly Report
    • 2026-01-08 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-10-30 8-K Officer/Director Change; Other Events; Financial Statements and Exhibits
    • 2025-10-28 8-K/A Officer/Director Change; Financial Statements and Exhibits
    • 2025-10-09 10-Q Quarterly Report
    • 2025-10-09 8-K Earnings Release; Financial Statements and Exhibits